DARATUMUMAB AND HYALURONIDASE-FIHJ | B761145 | JANSSEN BIOTECH
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | May. 1, 2032 | Active | Computed |
| 7-Year Orphan | Jan. 15, 2028 | Active | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12365743(composition) · relevance 55/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
35 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.